Harry Alcorn, Jr.
2019
In 2019, Harry Alcorn, Jr. earned a total compensation of $778.3K as Chief Medical Officer at DiaMedica Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $68,400 |
|---|---|
| Option Awards | $421,750 |
| Salary | $273,750 |
| Other | $14,400 |
| Total | $778,300 |
Alcorn received $421.8K in option awards, accounting for 54% of the total pay in 2019.
Alcorn also received $68.4K in non-equity incentive plan, $273.8K in salary and $14.4K in other compensation.
Rankings
In 2019, Harry Alcorn, Jr.'s compensation ranked 10,331st out of 13,971 executives tracked by ExecPay. In other words, Alcorn earned more than 26.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,331 out of 13,971 | 26th |
Division Manufacturing | 4,181 out of 5,701 | 27th |
Major group Chemicals And Allied Products | 1,606 out of 2,200 | 27th |
Industry group Drugs | 1,375 out of 1,886 | 27th |
Industry Pharmaceutical Preparations | 1,024 out of 1,398 | 27th |
Source: SEC filing on April 20, 2020.
Alcorn's colleagues
We found two more compensation records of executives who worked with Harry Alcorn, Jr. at DiaMedica Therapeutics in 2019.